Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
targeting cd39 in cancer | 0.88 | 0.3 | 80 | 19 | 24 |
targeting | 1.08 | 0.1 | 4874 | 94 | 9 |
cd39 | 1.57 | 0.2 | 655 | 86 | 4 |
in | 1.25 | 0.6 | 5742 | 21 | 2 |
cancer | 0.58 | 0.3 | 1408 | 84 | 6 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
targeting cd39 in cancer | 0.37 | 0.5 | 4415 | 55 |
cd93 in cancer 2023 | 1.58 | 0.2 | 7144 | 91 |
cd93 in cancer 2024 | 0.88 | 0.3 | 436 | 64 |
what is cd3 in cancer | 1.27 | 0.9 | 4413 | 68 |
cd39 t cell marker | 1.94 | 0.8 | 3441 | 70 |
targeting cdk4 and cdk6 in cancer | 0.8 | 0.6 | 4390 | 62 |
cd39 regulation and functions in t cells | 0.01 | 0.4 | 6828 | 30 |
targeting cdk4/6 in patients with cancer | 0.74 | 0.9 | 8860 | 79 |
tdt and cd3 cancer | 1.52 | 0.6 | 1086 | 78 |
single cell sequencing reveals that cd39 | 0.05 | 0.9 | 7892 | 80 |
cd95 promotes tumour growth | 0.58 | 0.5 | 1628 | 58 |
targeting cdk4/6 for anticancer therapy | 1.42 | 0.4 | 7645 | 78 |
cd39+ cd8+ t cell | 0.54 | 0.6 | 1902 | 29 |
cd39/cd73 | 1.06 | 0.5 | 7270 | 31 |
cd39+cd8+ | 0.46 | 0.2 | 1745 | 92 |
cd39+ cd4+ t cell | 1.4 | 0.3 | 4328 | 93 |
cd73/cd39 | 0.42 | 0.5 | 2579 | 83 |
cd8 on cd39+ cd8br | 1.11 | 0.9 | 9017 | 5 |
cd8+cd39+ | 0.42 | 0.7 | 8614 | 56 |
cd3 t cell marker | 0.63 | 0.2 | 1560 | 77 |
cd8 on cd39+ cd8+ t cell | 0.82 | 0.8 | 2409 | 37 |
cd3 t cell engager | 0.44 | 1 | 9647 | 59 |